Thu, September 15, 2022
Wed, September 14, 2022
Tue, September 13, 2022

Liisa Bayko Upgraded (AKRO) to Buy and Increased Target to $50 on, Sep 14th, 2022

Liisa Bayko of Evercore ISI Group, Upgraded "Akero Therapeutics, Inc." (AKRO) to Buy and Increased Target from $10 to $50 on, Sep 14th, 2022.

Liisa, nor any peers, have made any analyst calls on AKRO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30